Belarus, a landlocked country in Eastern Europe, is witnessing a growing demand for Sensory Organ Drugs.
Customer preferences: The Belarusian population is aging, and with age, sensory organs such as eyes, ears, and nose tend to weaken, leading to several related health issues. This has resulted in a rise in demand for sensory organ drugs, especially for the treatment of age-related macular degeneration, glaucoma, and cataracts. Moreover, with the increasing use of electronic devices, eye-related problems such as dry eyes and eye strain have become more prevalent, leading to a surge in demand for eye drops and ointments.
Trends in the market: The Sensory Organ Drugs market in Belarus is witnessing a shift towards generic drugs, which are more affordable compared to branded ones. The government's efforts to promote the use of generic drugs have resulted in an increase in the production and consumption of such drugs. Additionally, there is a growing trend towards self-medication, leading to an increase in the sales of over-the-counter (OTC) drugs. Online pharmacies are gaining popularity, especially among the younger population, due to their convenience and accessibility.
Local special circumstances: Belarus has a well-established pharmaceutical industry, with several domestic companies producing a wide range of drugs, including sensory organ drugs. The government has been actively promoting the local production of drugs, which has resulted in increased investment in the sector. Moreover, the country has a centralized healthcare system, with the government being the major buyer of drugs. This has resulted in a stable market for pharmaceutical companies, with a guaranteed demand for drugs.
Underlying macroeconomic factors: Belarus has a stable economy, with a low unemployment rate and a high literacy rate. The government's efforts to promote the local production of drugs have resulted in increased investment in the sector, leading to job creation and economic growth. Moreover, the country has a well-developed healthcare system, with a high level of healthcare expenditure per capita. This has resulted in a high demand for drugs, including sensory organ drugs. However, the country's dependence on Russia for its energy needs and its political situation are potential risks to the economy and the pharmaceutical industry.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
